NCT04938609 2026-04-09
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
Providence Health & Services
Phase 2 Active not recruiting
Providence Health & Services
University Hospital, Ghent
University of Pittsburgh
McMaster University
National Cancer Institute (NCI)